Graybill Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $752K | Hold |
818
| – | – | 0.23% | 57 |
|
|
2025
Q4 | $879K | Sell |
818
-50
| -6% | -$47.8K | 0.26% | 55 |
|
|
2025
Q3 | $662K | Hold |
868
| – | – | 0.2% | 57 |
|
|
2025
Q2 | $677K | Sell |
868
-2
| -0.2% | -$1.55K | 0.22% | 57 |
|
|
2025
Q1 | $719K | Buy |
+870
| New | +$724K | 0.25% | 56 |
|
|
2024
Q3 | $793K | Buy |
895
+45
| +5% | +$40.5K | 0.29% | 48 |
|
|
2024
Q2 | $770K | Sell |
850
-50
| -6% | -$40K | 0.31% | 48 |
|
|
2024
Q1 | $700K | Hold |
900
| – | – | 0.3% | 46 |
|
|
2023
Q4 | $525K | Sell |
900
-100
| -10% | -$58.4K | 0.23% | 49 |
|
|
2023
Q3 | $537K | Sell |
1,000
-1,391
| -58% | -$717K | 0.26% | 48 |
|
|
2023
Q2 | $1.12M | Sell |
2,391
-176
| -7% | -$73.8K | 0.53% | 44 |
|
|
2023
Q1 | $882K | Buy |
2,567
+1,125
| +78% | +$379K | 0.45% | 45 |
|
|
2022
Q4 | $528K | Hold |
1,442
| – | – | 0.29% | 45 |
|
|
2022
Q3 | $466K | Buy |
1,442
+50
| +4% | +$15.8K | 0.28% | 44 |
|
|
2022
Q2 | $451K | Buy |
1,392
+1
| +0.1% | +$300 | 0.25% | 45 |
|
|
2022
Q1 | $398K | Buy |
1,391
+223
| +19% | +$57.4K | 0.19% | 45 |
|
|
2021
Q4 | $323K | Hold |
1,168
| – | – | 0.15% | 47 |
|
|
2021
Q3 | $270K | Sell |
1,168
-1,650
| -59% | -$407K | 0.13% | 47 |
|
|
2021
Q2 | $647K | Hold |
2,818
| – | – | 0.32% | 45 |
|
|
2021
Q1 | $526K | Buy |
2,818
+48
| +2% | +$9.39K | 0.28% | 44 |
|
|
2020
Q4 | $468K | Sell |
2,770
-200
| -7% | -$29.9K | 0.26% | 42 |
|
|
2020
Q3 | $440K | Buy |
2,970
+600
| +25% | +$92.9K | 0.29% | 45 |
|
|
2020
Q2 | $389K | Hold |
2,370
| – | – | 0.29% | 43 |
|
|
2020
Q1 | $329K | Hold |
2,370
| – | – | 0.29% | 40 |
|
|
2019
Q4 | $311K | Hold |
2,370
| – | – | 0.19% | 42 |
|
|
2019
Q3 | $265K | Sell |
2,370
-125
| -5% | -$13.9K | 0.18% | 46 |
|
|
2019
Q2 | $276K | Sell |
2,495
-70
| -3% | -$8.24K | 0.19% | 41 |
|
|
2019
Q1 | $333K | Hold |
2,565
| – | – | 0.23% | 43 |
|
|
2018
Q4 | $297K | Hold |
2,565
| – | – | 0.25% | 42 |
|
|
2018
Q3 | $275K | Hold |
2,565
| – | – | 0.2% | 44 |
|
|
2018
Q2 | $219K | Buy |
+2,565
| New | +$211K | 0.17% | 47 |
|
|
2018
Q1 | – | Sell |
-3,108
| Closed | -$263K | – | 46 |
|
|
2017
Q4 | $263K | Hold |
3,108
| – | – | 0.19% | 46 |
|
|
2017
Q3 | $266K | Buy |
3,108
+355
| +13% | +$29.1K | 0.2% | 45 |
|
|
2017
Q2 | $227K | Hold |
2,753
| – | – | 0.18% | 45 |
|
|
2017
Q1 | $232K | Hold |
2,753
| – | – | 0.18% | 45 |
|
|
2016
Q4 | $202K | Hold |
2,753
| – | – | 0.17% | 43 |
|
|
2016
Q3 | $221K | Hold |
2,753
| – | – | 0.21% | 43 |
|
|
2016
Q2 | $217K | Buy |
+2,753
| New | +$207K | 0.2% | 45 |
|
|
2016
Q1 | – | Sell |
-2,606
| Closed | -$220K | – | 46 |
|
|
2015
Q4 | $220K | Hold |
2,606
| – | – | 0.19% | 46 |
|
|
2015
Q3 | $218K | Hold |
2,606
| – | – | 0.18% | 49 |
|
|
2015
Q2 | $218K | Buy |
+2,606
| New | +$199K | 0.16% | 51 |
|
Other funds holding LLY
VCM
VPM
Graybill Wealth Management's LLY Position: Q1 2026 in Review
Graybill Wealth Management held its Eli Lilly (LLY) position steady in Q1 2026 at 818 shares worth $752K. The position accounts for 0.23% of the portfolio, ranked #57.
Graybill Wealth Management first reported a position in LLY in Q2 2015 and has held it in 41 quarters since. The position peaked at $1.12M in Q2 2023. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Graybill Wealth Management held 818 shares of Eli Lilly worth $752K as of Q1 2026.
- Graybill Wealth Management left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.23% of Graybill Wealth Management's portfolio in Q1 2026, its #57 holding.
- Graybill Wealth Management first reported a position in Eli Lilly in Q2 2015 and has held it in 41 quarters since.
- Graybill Wealth Management's Eli Lilly position peaked at $1.12M in Q2 2023.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Graybill Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.